ITIH4: A New Potential Biomarker of “Toxin Syndrome” in Coronary Heart Disease Patient Identified with Proteomic Method

<table class="table-group" id="tab5"><tr><td><table class="table"><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr class="thead"><td align="left">Mass</td><td align="center">IPI</td><td align="left">Gene_Symbol</td><td align="center">Amino acid sequence</td></tr><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr><td align="left">4280.13 Da</td><td align="center">IPI00218192.3</td><td align="left">ITIH4 Isoform 2 of inter-alpha-trypsin inhibitor heavy chain H4</td><td align="center">R.NVHSAGAAGSRMNFRPGVLSSRQLGLPGPPDVPDHAAYHPF.R</td></tr><tr><td align="left" colspan="4"><hr/></td></tr><tr><td align="left">3206.42 Da</td><td align="center">IPI00021885.1</td><td align="left">FGA Isoform 1 of Fibrinogen alpha chain precursor</td><td align="center">K.SSSYSKQFTSSTSYNRGDSTFESKSYKM*.A</td></tr><tr class="table-tr"><td colspan="4"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Peptides identification unique to “Toxin”.

Evidence-Based Complementary and Alternative Medicine

tab5

Table 5

Table 5: ITIH4: A New Potential Biomarker of “Toxin Syndrome” in Coronary Heart Disease Patient Identified with Proteomic Method 